Clinical Trials Browser

Phase 1/2 × Completed × 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide × Clear all

NCT00790218 2022-05-17

A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular Carcinoma

Phase 1/2 Completed

19 enrolled 6 charts

Gastrointestinal

Carcinoma, Hepatocellular